A Phase 1, Open-Label, Single Ascending Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of ES-481 After Oral Administration in Healthy Volunteers.

Saved in:
Bibliographic Details
Title: A Phase 1, Open-Label, Single Ascending Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of ES-481 After Oral Administration in Healthy Volunteers.
Authors: Niecestro R; ES-Therapeutics, New York, NY, USA. rniecestro@estherapeutics.com.; ES Therapeutics, Inc., 13053 Big Bear Bluff, Boynton Beach, FL, 33473, USA. rniecestro@estherapeutics.com., Foster EC; Department of Neuroscience, The School of Translational Medicine, Monash University, Melbourne, VIC, 3004, Australia.; Department of Neurology, Alfred Health, Commercial Road, Melbourne, VIC, 3000, Australia., Millist L; Department of Neuroscience, The School of Translational Medicine, Monash University, Melbourne, VIC, 3004, Australia., Germaine J; Department of Neuroscience, The School of Translational Medicine, Monash University, Melbourne, VIC, 3004, Australia., Niecestro A; ES-Therapeutics, New York, NY, USA., O'Brien TJ; Department of Neuroscience, The School of Translational Medicine, Monash University, Melbourne, VIC, 3004, Australia.; Department of Neurology, Alfred Health, Commercial Road, Melbourne, VIC, 3000, Australia.
Source: European journal of drug metabolism and pharmacokinetics [Eur J Drug Metab Pharmacokinet] 2026 Jan; Vol. 51 (1), pp. 97-109. Date of Electronic Publication: 2026 Jan 05.
Publication Type: Journal Article; Clinical Trial, Phase I; Randomized Controlled Trial
Journal Info: Publisher: Springer France Country of Publication: France NLM ID: 7608491 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2107-0180 (Electronic) Linking ISSN: 03787966 NLM ISO Abbreviation: Eur J Drug Metab Pharmacokinet Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2107-0180
DOI:10.1007/s13318-025-00979-8